=====================  Product Identification  =====================

Product ID:SORBITRATE TABLETS
MSDS Date:08/25/1987
FSC:6505
NIIN:01-031-4983
MSDS Number: BHWXR
=== Responsible Party ===
Company Name:ICI AMERICAS INC.,ICI PHARMACEUTICALS DIV
Address:CONCORD PIKE AND MURPHY ROAD
City:WILMINGTON
State:DE
ZIP:19897
Country:US
Info Phone Num:302-886-3000
Emergency Phone Num:800-327-8633 MEDICAL
CAGE:0A273
=== Contractor Identification ===
Company Name:ZENECA INC., ZENECA PHARMACEUTICALS GROUP
Address:1800 CONCORD PIKE
Box:City:WILMINGTON
State:DE
ZIP:19803-2902
Country:US
Phone:302-886-3000
CAGE:0A273

=============  Composition/Information on Ingredients  =============

Ingred Name:ISOSORBIDE DINITRATE MIXTURE
CAS:87-33-2
RTECS #:LZ4386000
Other REC Limits:S, 0.2 MG/M3

Ingred Name:OTHER COMPONENTS (PROPIETARY OR NONHAZARDOUS PER
    MANUFACTURER)

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:LD50 ORAL RAT IS 2000 MG/KG.
Routes of Entry: Inhalation:NO	Skin:NO  Ingestion:NO
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:ISOSORBIDE DINITRATE CAN BE SLOWLY
    ABSORBED THROUGH SKIN, BUT IN TABLET FORM, NO ABSORPTION IS LIKELY
    TO OCCUR. RELATIVE TO OTHER MATERIALS, A SINGLE DOSE OF THIS
    PRODUCT IS SLIGHTLY TOXIC BY INGESTIO N. TABLETS ARE NOT LIKELY TO
    BE INHALED, BUT ANY DUST CAN BE SLOWLY ABSORBED THROUGH MUCOUS
    MEMBRANES.
Effects of Overexposure:ADVERSE EFFECTS FROM SEVERE OVEREXPOSURE CAN
    INCLUDE FLUSHING AND PERSPIRING SKIN, VISUAL DISTURBANCE, HEADACHE,
    HYPOTENSION, GASTROINTESTINAL DISTRBANCE, CENTRAL NERVOUS SYSTEM
    DEPRESSION AND CYANOSI S FOLLOWED BY CONVULSIONS, UNCONSCIOUSNESS,
    SLOW BREATHING AND CIRCULATORY COLLAPSE.
Medical Cond Aggravated by Exposure:NONE NOTED.

=======================  First Aid Measures  =======================

First Aid:EYES:IMMEDIATELY FLUSH WITH PLENTY OF WATER FOR AT LEAST 15
    MINTES.IF SYMPTOMS PERSIST,SEE DOCTOR. SKIN:WASH WITH PLENTY OF
    SOAP AND WATER.IF SYMPTOMS PERSIST,SEE DOCTOR. INHALATION:REMOVE TO
    FRESH AI R,IF NOT BREATHING,GIVE CPR.IF BREATHING IS DIFFICULT,GIVE
    OXYGEN. INGESTION:GIVE 1-2 GLASSES OF WATER.INDUCE VOMIT.NOTHING BY
    MOUTH IF UNCONSCIOUS.SEE DOCTOR.

=====================  Fire Fighting Measures  =====================

Extinguishing Media:USE CARBON DIOXIDE, FOAM, DRY CHEMICAL, OR WATER
    FOG.
Fire Fighting Procedures:WEAR SCBA AND FULL PROTECTIVE EQUIPMENT. USE
    BARRICADE DUE TO POSSIBILITY OF EXPLOSION. IF FIRE CANNOT BE
    CONTROLLED IN EARLY STAGES, EVACUATE TO SAFE DISTANCE.
Unusual Fire/Explosion Hazard:CONCENTRATED ISOSORBIDE DINITRATE IS A
    POWERFUL EXPLOSIVE. WATER WILL DISSOLVE AWAY OTHER INGREDIENTS AND
    CONCENTRATE ISOSORBIDE. THIS IS EXTREMELY HAZARDOUS.

==================  Accidental Release Measures  ==================

Spill Release Procedures:WEAR SKIN PROTECTION DURING CLEANUP. SWEEP UP
    AND RECOVER. WET MATERIAL WITH WATER IN A PLASTIC BAG. WHEN TABLETS
    BEGIN TO DISINTEGRATE, DISCARD WITH GENERAL TRASH. WASH RESIDUE
    WITH WATER AND FLUSH T O A SEWER SERVICED BY WASTEWATER TREATMENT
    FACILTY

======================	Handling and Storage  ======================

Handling and Storage Precautions:AVOID BREATHING DUST. PREVENT SKIN
    CONTACT.
Other Precautions:EMPTY CONTAINERS CONTAIN PRODUCT RESIDUE. DO NOT
    REUSE EXCEPT FOR STORAGE OR SHIPMENT OF ORIGINAL PRODUCT. REMOVE
    ALL PRODUCT RESIDUE AND PUNCTURE OR OTHERWISE DESTROY EMPTY
    CONTAINER BEFORE DISPOSAL.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:NOT NEEDED WITH ADEQUATE VENTILATION. OTHERWISE,
    USE NIOSH/MSHA APPROVED RESPIRATOR IF DUST IS THE ONLY CONCERN.
    THERE IS NO AIR PURIFYING RESPIRATOR APPROVED FOR ISOSORBIDE
    DINITRATE. ORGANIC CARTRID GES ARE NOT ADEQUATE.
Ventilation:LOCAL EXHAUST.
Protective Gloves:COTTON GLOVES OVER THIN LATEX GLOVES.
Eye Protection:SAFETY GLASSES WITH SIDE SHIELD.
Other Protective Equipment:EYE WASH STATION.
Work Hygienic Practices:HANDS AND FACE SHOULD BE THOROUGHLY WASHED WITH
    SOAP AND WATER PRIOR TO EATING, DRINKING OR SMOKING.
Supplemental Safety and Health
NOTE TO PHYSICIAN:SEVERE OVEREXPOSURE CAN LEAD TO METHEMOGLOBIN
    FORMATION,WHICH IN SUFFICIENT CONCENTRATION RESULTS IN CLINICAL
    CYANOSIS.IF MODERATE,TREAT ONLY BY SUPPORTIVE MEASURES.IF
    SEVERE,INTRAVE NOUSLY ADMINISTER 1% METHYLENE BLUE,1-2MG/KG BODY
    WEIGHT OVER 5 MINUTES INTERVAL.DO NOT EXCEED 7 MG/KG TOTAL DOSE.

==================  Physical/Chemical Properties  ==================

HCC:N1
Melt/Freeze Pt:M.P/F.P Text:158F,70C
Solubility in Water:SLIGHT
Appearance and Odor:TABLETS
Percent Volatiles by Volume:NEGL.

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
WATER, ACIDS, ALKALIES, OXIDIZING AGENTS.
Stability Condition to Avoid:HEAT.
Hazardous Decomposition Products:CARBON DIOXIDE, CARBON MONOXIDE,
    NITROGEN OXIDES.

====================  Disposal Considerations  ====================

Waste Disposal Methods:DISCARDED PRODUCT IS NOT A HAZARDOUS WASTE UNDER
    RCRA, 40CFR261. DISPOSE OF IN ACCORDANCE WITH ALL APPLICABLE
    FEDERAL, STATE AND LOCAL REGULATIONS

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.
